eCF506

• CAT Number: I006583
• CAS Number: 1914078-41-3
• Molecular Formula: C26H38N8O3
• Molecular Weight: 510.64
• Purity: ≥95%
• Synonyms: eCF506; eCF-506; eCF 506.;tert-butyl (4-(4-amino-1-(2-(4-(dimethylamino)piperidin-1-yl)ethyl)-1H-pyrazolo[3,4-d]pyrimidin-3-yl)-2-methoxyphenyl)carbamate
• Target: Src
• Solubility: Soluble in DMSO, not in water
• Storage: 0 - 4°C for short term or -20 °C for long term
• IUPAC Name: tert-butyl N-[4-[4-amino-1-[2-[4-(dimethylamino)piperidin-1-yl]ethyl]pyrazolo[3,4-d]pyrimidin-3-yl]-2-methoxyphenyl]carbamate
• InChI: InChI=1S/C26H38N8O3/c1-26(2,3)37-25(35)30-19-8-7-17(15-20(19)36-6)22-21-23(27)28-16-29-24(21)34(31-22)14-13-33-11-9-18(10-12-33)32(4)5/h7-8,15-16,18H,9-14H2,1-6H3,(H,30,35)(H2,27,28,29)
• InChIKey: GMPQGWXPDRNCBL-UHFFFAOYSA-N
• SMILES: COC1=CC(C2=NN(CCN3CCC(N(C)C)CC3)C4=NC=NC(N)=C42)=CC=C1NC(OC(C)(C)C)=O

eCF506(CAT: I006583) is a highly selective Src kinase inhibitor, widely recognized for its applications in oncology research. It targets the Src family of kinases, which are key regulators of cancer cell proliferation, migration, and survival. By inhibiting Src signaling, eCF506 provides valuable insights into tumor progression, metastasis, and drug resistance mechanisms. Its specificity and potency make it an excellent candidate for preclinical studies, particularly in investigating targeted cancer therapies. eCF506 serves as a critical tool in advancing the understanding of Src kinase biology and developing innovative therapeutic approaches in cancer treatment.